Comparison of Efficacy of Micropulse Laser Settings for Glaucoma Management. [PDF]
Objectives: This study aims to compare micropulse transscleral cyclophotocoagulation (MP-TSCPC) laser parameters and determine the optimal laser setting. Methods: A retrospective study was performed on 351 eyes from patients who underwent MP-TSCPC at four power settings (1500 mW, 2000 mW, 2250 mW, and 2500 mW) from June 2018 to December 2021.
Kim EY +6 more
europepmc +3 more sources
Micropulse Laser Trabeculoplasty in Glaucoma: Efficacy and Safety in a Clinical Cohort. [PDF]
Background and Objectives: Glaucoma is a leading cause of irreversible blindness, and lowering intraocular pressure (IOP) is the only proven strategy to slow disease progression. We evaluated the clinical efficacy and safety of Micropulse Laser Trabeculoplasty (MLT) in patients with open-angle glaucoma and ocular hypertension, focusing on IOP control ...
Bodea FI +5 more
europepmc +3 more sources
Purpose: the article presents arguments for changing the traditional operation name “micropulse cyclophotocoagulation”. In accordance with the potential mechanisms involved, a new name is proposed — “micropulse transscleral laser cycloplasty”.
I. E. Ioshin
doaj +2 more sources
Selective laser trabeculoplasty vs micropulse laser trabeculoplasty in open-angle glaucoma
Benjamin Abramowitz,1 Nisha Chadha,2 Amr Kouchouk,3 Rashed Alhabshan,4 David A Belyea,4 Tania Lamba4 1Glaucoma Department, Eye Consultants of Northern Virginia, Springfield, VA, USA; 2Icahn School of Medicine at Mount Sinai/New York Eye and Ear, Eye and
Abramowitz B +5 more
doaj +5 more sources
Settings and Clinical Applications of Subthreshold Micropulse Laser Therapy: A Review. [PDF]
Subthreshold lasers operate below the threshold of visible tissue damage, thereby preventing ophthalmoscopically visible thermal damage to the chorio-retinal layers. They could represent a safe and effective alternative and/or adjunctive procedure to conventional lasers in treating diabetic macula edema (DME), central serous chorioretinopathy (CSCR ...
Sorrentino T +9 more
europepmc +4 more sources
A Review of Subthreshold Micropulse Laser and Recent Advances in Retinal Laser Technology
The role of retinal photocoagulation as a first line therapy for various retinal pathologies has decreased with the introduction of anti-vascular endothelial growth factor therapy. However, retinal laser therapy remains an important treatment modality, especially with the emergence of micropulse subthreshold treatment and the integration of newer ...
Jean-Pierre Hubschman +2 more
exaly +5 more sources
Subthreshold Micropulse Laser (577 nm) Therapy with an Individual Approach for Power Titration in Patients with Chronic Central Serous Chorioretinopathy (Pilot Study) [PDF]
Purpose. To study the safety and effectiveness of subthreshold micropulse (SML) 577 nm laser therapy with an individual power titration in treating patients with chronic central serous chorioretinopathy (CSC). Methods. The study was a prospective, single-
Taras Kustryn +4 more
doaj +2 more sources
Micropulse laser trabeculoplasty for open-angle glaucoma
Purpose The aim of this study was to evaluate the pressure-lowering effect of 577 nm micropulse laser trabeculoplasty in eyes treated for primary open-angle glaucoma. Patients and methods This prospective interventional case series included 30 eyes of 30
Mahmoud A Abouhussein
doaj +2 more sources
Comparative study between subthreshold (micropulse) laser direct application to the edematous macula versus direct application to the peripheral healthy retina in the treatment of diabetic macular edema. [PDF]
Background: Subthreshold (micropulse) laser is an effective modality in the treatment of diabetic macular edema that avoids possible complications of conventional laser photocoagulation and anti-vascular endothelial growth factor. Regardless of where the
Eslam Alharif, Hamed Taha, Mohamed Rahed
doaj +1 more source
Background At present, intraocular injection of anti-VEGF (vascular endothelial growth factor) drugs has replaced traditional laser therapy as the first-line treatment for DME (diabetic macular edema). However, ranibizumab, a commonly used anti-VEGF drug,
Xuejing Mi, Xiaoya Gu, Xiaobing Yu
doaj +1 more source

